15-LO inhibitors (Bristol-Myers Squibb)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name15-LO inhibitors (Bristol-Myers Squibb)
Drug Alias Name15-lipoxygenase inhibitors (BMS)15-LO inhibitors (BMS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsInflammationAtherosclerosisPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsInflammationAtherosclerosisPulmonary Disease, Chronic Obstructive +[4] 

Other Information

ATC CodeN/A
Related LinksN/A